All locations will be closing at 4 p.m due to the weather.

CBD Studies Database - Lyme's Disease

Although there are not yet any research studies directly on how CBD affects Lyme’s disease, there are many studies that discuss how CBD can affect symptoms of Lyme’s disease such as social anxiety, joint and muscle pain, inflammation of the brain, and so on. Check out the studies below to learn more!

 

Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes
This study explored the effects of the major non psychotropic phytocannabinoid of Cannabis sativa and cannabidiol (CBD) on human sebaceous gland function and determined that CBD behaves as a highly effective sebostatic agent.

Read the full study here.

Cannabidiol Is a Novel Modulator of Bacterial Membrane Vesicles
This study investigated if known anti-bacterial effects of cannabidiol (CBD), a phytocannabinoid from Cannabis sativa, could be in part attributed to effects on bacterial membrane vesicles (MV) profile and MV release.
Read the full study here.
.
Cannabidiol, neuroprotection and neuropsychiatric disorders
This study summarized the main biochemical and molecular mechanisms that have been associated with the therapeutic effects of CBD, focusing on their relevance to brain function, neuroprotection and neuropsychiatric disorders.
Read the full study here.
.
The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
This study reviews in vivo(inside a living organism) and in vitro(outside a living organism) studies of CB2 receptors in microglia, including results on CB2 expression post-injury.
Read the full study here.
.
Cannabinoids in the management of difficult to treat pain
This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized clinical trials employing cannabinoids in pain treatment.
Read the full study here.
Unorthodox Alternative Therapies Marketed to Treat Lyme Disease
This study was designed to identify and characterize the range of unorthodox alternative therapies advertised to patients with a diagnosis of Lyme disease.

Read the full study here.

Cannabidiol as an Emergent Therapeutic Strategy for Lessening the Impact of Inflammation on Oxidative Stress
This review discusses recent studies suggesting that cannabidiol may have utility in treating a number of human diseases and disorders now known to involve activation of the immune system and associated oxidative stress, as a contributor to their etiology and progression. These include rheumatoid arthritis, types I and II diabetes, atherosclerosis, Alzheimer’s disease, hypertension, the metabolic syndrome, ischemia-reperfusion injury, depression, and neuropathic pain.
Read the full study here.
.
Post-treatment Lyme Disease as a Model for Persistent Symptoms in Lyme Disease
The aim of this paper is to review the current literature on the diagnosis, etiology, risk factors, and treatment of patients with persistent symptoms in the context of Lyme disease. The meaning and relevance of existing patient subgroups will be discussed, as will future research priorities, including the need to develop illness biomarkers, elucidate the biologic mechanisms of disease, and drive improvements in therapeutic options.

Read the full study here.